199 related articles for article (PubMed ID: 10854145)
21. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel.
Grim J; D'Amico A; Frizelle S; Zhou J; Kratzke RA; Curiel DT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2415-23. PubMed ID: 9815642
[TBL] [Abstract][Full Text] [Related]
22. Potential efficacy of p16 gene therapy for EBV-positive nasopharyngeal carcinoma.
Li AA; Ng E; Shi W; Lee A; Chia M; Liu TJ; Huang D; O'Sullivan B; Gullane P; Liu FF
Int J Cancer; 2004 Jun; 110(3):452-8. PubMed ID: 15095314
[TBL] [Abstract][Full Text] [Related]
23. Differential protein expressions induced by adenovirus-mediated p16 gene transfer into Balb/c nude mouse.
Kim O; Park M; Kang H; Lim S; Lee CT
Proteomics; 2003 Dec; 3(12):2412-9. PubMed ID: 14673791
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
25. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector.
Asgari K; Sesterhenn IA; McLeod DG; Cowan K; Moul JW; Seth P; Srivastava S
Int J Cancer; 1997 May; 71(3):377-82. PubMed ID: 9139872
[TBL] [Abstract][Full Text] [Related]
27. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells.
Fueyo J; Gomez-Manzano C; Yung WK; Clayman GL; Liu TJ; Bruner J; Levin VA; Kyritsis AP
Oncogene; 1996 Jan; 12(1):103-10. PubMed ID: 8552379
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated gene transfer of P16INK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo.
Tamm I; Schumacher A; Karawajew L; Ruppert V; Arnold W; Nüssler AK; Neuhaus P; Dörken B; Wolff G
Cancer Gene Ther; 2002 Aug; 9(8):641-50. PubMed ID: 12136424
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus with p16 gene exerts antitumor effect on laryngeal carcinoma Hep2 cells.
Yang Z; Hu J; Li D; Pan X
Mol Med Rep; 2016 Aug; 14(2):1425-9. PubMed ID: 27277704
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated p16INK4 gene transfer significantly suppresses human breast cancer growth.
Campbell I; Magliocco A; Moyana T; Zheng C; Xiang J
Cancer Gene Ther; 2000 Sep; 7(9):1270-8. PubMed ID: 11023200
[TBL] [Abstract][Full Text] [Related]
33. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
Zhang F; Lu W; Dong Z
Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.
Li X; Zhang YP; Kim HS; Bae KH; Stantz KM; Lee SJ; Jung C; Jiménez JA; Gardner TA; Jeng MH; Kao C
Cancer Res; 2005 Mar; 65(5):1941-51. PubMed ID: 15753394
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer.
Kaliberov SA; Kaliberova LN; Stockard CR; Grizzle WE; Buchsbaum DJ
Mol Ther; 2004 Dec; 10(6):1059-70. PubMed ID: 15564138
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway.
Arap W; Knudsen E; Sewell DA; Sidransky D; Wang JY; Huang HJ; Cavenee WK
Oncogene; 1997 Oct; 15(17):2013-20. PubMed ID: 9366518
[TBL] [Abstract][Full Text] [Related]
37. [Influence of p16 gene on the biological behavior of human hepatocellular carcinoma].
Huang JZ; Xia SS; Ye QF; Jiang HY
Ai Zheng; 2003 Jan; 22(1):46-9. PubMed ID: 12561435
[TBL] [Abstract][Full Text] [Related]
38. Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy.
Tamura RE; da Silva Soares RB; Costanzi-Strauss E; Strauss BE
Cancer Biol Ther; 2016 Dec; 17(12):1221-1230. PubMed ID: 27646031
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro.
Chintala SK; Fueyo J; Gomez-Manzano C; Venkaiah B; Bjerkvig R; Yung WK; Sawaya R; Kyritsis AP; Rao JS
Oncogene; 1997 Oct; 15(17):2049-57. PubMed ID: 9366522
[TBL] [Abstract][Full Text] [Related]
40. Combination radiation and adenovirus-mediated P16(INK4A) gene therapy in a murine model for head and neck cancer.
Rhee JG; Li D; O'Malley BW; Suntharalingam M
ORL J Otorhinolaryngol Relat Spec; 2003; 65(3):144-54. PubMed ID: 12925815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
